Company Filing History:

7 out of 340

Behringwerke Aktiengesellschaft

patents

2 out of 6,662

Hoechst Aktiengesellschaft

patents

2 out of 330

Aventis Pharma Deutschland, Gmbh

Dade Behring Marburg Gmbh

where one patent can have more than one assignee

Years Active: 1980-2010

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7662383 - Chimeric antibody against tumor associated antigens and its use in diagnosing tumors (2010-02-16),

2. 6926896 - Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof (2005-08-09),

3. 6294172 - Monoclonal antibodies with specificity for membrane-associated antigens (2001-09-25),

4. 5643731 - Use of pairs of leucine zipper peptides in immunoassay methods (1997-07-01),

5. 5561119 - Glycosylated prodrugs, their method of preparation and their uses (1996-10-01),

6. 5284856 - Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one (1994-02-08),

7. 5189065 - Use of derivatives of 9,10-dihydrophenanthrene for the preparation of an (1993-02-23),

8. 5079263 - Manumycin derivatives and the use thereof (1992-01-07),

9. 5006515 - Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles (1991-04-09),

10. 4963577 - Use of the thiazole derivative tiprotimod for the preparation of an (1990-10-16),

11. 4847299 - Use of 15-deoxyspergualine as a pharmaceutical (1989-07-11),

12. 4801455 - Pharmaceutical formulation and process for its preparation (1989-01-31),

13. 4239743 - Carrier-bound immunoglobulin fission product and its use in immunologic (1980-12-16),

Title: Innovations and Contributions of Hans H Sedlacek

Introduction

Hans H Sedlacek is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies for cancer diagnosis and therapy. With a total of 13 patents to his name, Sedlacek's work has had a profound impact on medical research and treatment options.

Latest Patents

Among his latest patents is the invention of a chimeric antibody against tumor-associated antigens and its use in diagnosing tumors. This invention involves murine monoclonal antibodies (MAbs) that target tumor-associated antigens. The nearly complete nucleotide sequences of the variable genes of these MAbs are described, allowing for the assembly of chimeric MAbs. Additionally, 'humanized' MAbs can be created by inserting hypervariable regions into a human MAb framework. These antibody constructs can be utilized in human therapy and in vivo diagnosis, overcoming the limitations associated with murine MAbs. Another significant patent involves the preparation and use of monoclonal antibodies against tumor-associated antigens, further emphasizing his innovative approach to cancer treatment.

Career Highlights

Throughout his career, Hans H Sedlacek has worked with prominent companies in the biotechnology sector, including Behringwerke Aktiengesellschaft and Hoechst Aktiengesellschaft. His experience in these organizations has contributed to his expertise in the development of therapeutic antibodies.

Collaborations

Sedlacek has collaborated with notable colleagues such as Klaus Bosslet and Gerhard Dickneite, enhancing the scope and impact of his research.

Conclusion

Hans H Sedlacek's contributions to the field of biotechnology, particularly in the development of monoclonal antibodies, have paved the way for advancements in cancer diagnosis and treatment. His innovative patents and collaborations reflect his commitment to improving medical outcomes through scientific research.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.